Welcome to "Lung Cancer 201: Expanding Horizons," our new series focusing on the challenges unique to established programs, clinicians, researchers, and advocates. You've made it past the first hurdle; time to explore what's next.

In this first episode, Dr. Ella Kazerooni sits down with Dr. Robert Smith and Dr. Gerard Silvestri to discuss advances in the lung cancer space in 2022, including the "One Million Screens" paper, the benefits of the roundtable model, and National Lung Cancer Screening Day.

Ella A. Kazerooni, MD, is a Professor of Radiology & Internal Medicine, and serves as the Associate Chief Clinical Officer for the Diagnostic and Clinical Information Oversight Team within the University of Michigan Medical Group (UMMG). Dr. Kazerooni is the inaugural chair of the American Cancer Society’s Lung Cancer Roundtable (NLCRT), current Chair of the American College of Radiology's (ACR) lung cancer screening registry and LungRADS committee, and serves as the vice chair of the National Comprehensive Cancer Network Guideline on Lung Cancer Screening. Robert Smith, PhD, is a cancer epidemiologist and Senior Vice President, Cancer Screening at the American Cancer Society (ACS). Dr. Smith was one of the founding members of the National Colorectal Cancer Roundtable, and has served as its Co-Director for 20 years. He also is a founding member of the NLCRT and the Principle Investigator of the first 3-year supporting grant. Gerard Silvestri, MD, MS, is a lung cancer pulmonologist at the Medical University of South Carolina, and served on the DSMB of the national PLCO screening trial representing the lung arm of the trial as well as part of the epidemiology working group for the National Lung Screening Trial (NLST). Dr. Silvestri also serves as a Steering Committee member and Task Group Chair on the NLCRT.

Content note: this episode contains stigmatizing language. The American Cancer Society National Lung Cancer Roundtable and American College of Radiology are committed to the adoption of language, phrasing, and imagery that are person-first, judgment-free, and non-stigmatizing when discussing lung cancer. This shift in language takes time and dedicated effort, and slips happen. For information on how to eliminate lung cancer stigma in your speech patterns, written work, and presentations, please visit https://www.iaslc.org/IASLCLanguageGuide for the IASLC’s Language Guide.

Additional information on this episode’s topic and guests, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources. Access the recordings of the 2022 webinar series that inspired this podcast series at https://pages.acr.org/NLCRT_Accelerating_Screening_Uptake.html.